Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001144204-12-013695
Filing Date
2012-03-08
Accepted
2012-03-08 13:38:58
Documents
1
Period of Report
2012-03-01

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT v305103_form3.html 3  
1 OWNERSHIP DOCUMENT v305103_form3.xml 3 2139
  Complete submission text file 0001144204-12-013695.txt   3837
Mailing Address 414 NORTH ORLEANS STREET SUITE 502 CHICAGO IL 60610
Business Address 414 NORTH ORLEANS STREET SUITE 502 CHICAGO IL 60610 4078490290
CytoCore Inc (Issuer) CIK: 0000075439 (see all company filings)

EIN.: 364296006 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 3841 Surgical & Medical Instruments & Apparatus

Mailing Address C/O CYTOCORE INC. 414 N.ORLEANS ST., SUITE 502 CHICAGO IL 60654
Business Address
Scimia Mauro (Reporting) CIK: 0001543738 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-00935 | Film No.: 12676758